Cash & equivalents increased 214.6%
Cash & equivalents changed +214.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$5.9M→$18.6M4 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +214.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +39.4% from the comparable as-filed period.
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.